Global Hereditary Angioedema Market Research Report 2023

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

The global Hereditary Angioedema market was valued at US$ 1656.7 million in 2022 and is anticipated to reach US$ 2724.1 million by 2029, witnessing a CAGR of 7.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Hereditary Angioedema is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Hereditary Angioedema is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Hereditary Angioedema include Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema.

The Hereditary Angioedema market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hereditary Angioedema market comprehensively. Regional market sizes, concerning products by type, by distribution channel and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hereditary Angioedema manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel and by regions.

1.1 Product Overview and Scope of Hereditary Angioedema

1.2 Hereditary Angioedema Segment by Type

1.2.1 Global Hereditary Angioedema Market Value Comparison by Type (2023-2029)

1.2.2 C1 Esterase Inhibitor

1.2.3 Kallikrein Inhibitor

1.2.4 Selective Bradykinin B2 Receptor Antagonist

1.3 Hereditary Angioedema Segment by Distribution Channel

1.3.1 Global Hereditary Angioedema Market Value by Distribution Channel: (2023-2029)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Global Hereditary Angioedema Market Size Estimates and Forecasts

1.4.1 Global Hereditary Angioedema Revenue 2018-2029

1.4.2 Global Hereditary Angioedema Sales 2018-2029

1.4.3 Global Hereditary Angioedema Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Hereditary Angioedema Sales Market Share by Manufacturers (2018-2023)

2.2 Global Hereditary Angioedema Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Hereditary Angioedema Average Price by Manufacturers (2018-2023)

2.4 Global Hereditary Angioedema Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Hereditary Angioedema, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hereditary Angioedema, Product Type & Application

2.7 Hereditary Angioedema Market Competitive Situation and Trends

2.7.1 Hereditary Angioedema Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Players Market Share by Revenue

2.7.3 Global Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Hereditary Angioedema Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Hereditary Angioedema Global Hereditary Angioedema Sales by Region: 2018-2029

3.2.1 Global Hereditary Angioedema Sales by Region: 2018-2023

3.2.2 Global Hereditary Angioedema Sales by Region: 2024-2029

3.3 Global Hereditary Angioedema Global Hereditary Angioedema Revenue by Region: 2018-2029

3.3.1 Global Hereditary Angioedema Revenue by Region: 2018-2023

3.3.2 Global Hereditary Angioedema Revenue by Region: 2024-2029

3.4 North America Hereditary Angioedema Market Facts & Figures by Country

3.4.1 North America Hereditary Angioedema Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Hereditary Angioedema Sales by Country (2018-2029)

3.4.3 North America Hereditary Angioedema Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Hereditary Angioedema Market Facts & Figures by Country

3.5.1 Europe Hereditary Angioedema Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Hereditary Angioedema Sales by Country (2018-2029)

3.5.3 Europe Hereditary Angioedema Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hereditary Angioedema Market Facts & Figures by Country

3.6.1 Asia Pacific Hereditary Angioedema Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Hereditary Angioedema Sales by Country (2018-2029)

3.6.3 Asia Pacific Hereditary Angioedema Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Hereditary Angioedema Market Facts & Figures by Country

3.7.1 Latin America Hereditary Angioedema Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Hereditary Angioedema Sales by Country (2018-2029)

3.7.3 Latin America Hereditary Angioedema Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hereditary Angioedema Market Facts & Figures by Country

3.8.1 Middle East and Africa Hereditary Angioedema Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Hereditary Angioedema Sales by Country (2018-2029)

3.8.3 Middle East and Africa Hereditary Angioedema Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Hereditary Angioedema Sales by Type (2018-2029)

4.1.1 Global Hereditary Angioedema Sales by Type (2018-2023)

4.1.2 Global Hereditary Angioedema Sales by Type (2024-2029)

4.1.3 Global Hereditary Angioedema Sales Market Share by Type (2018-2029)

4.2 Global Hereditary Angioedema Revenue by Type (2018-2029)

4.2.1 Global Hereditary Angioedema Revenue by Type (2018-2023)

4.2.2 Global Hereditary Angioedema Revenue by Type (2024-2029)

4.2.3 Global Hereditary Angioedema Revenue Market Share by Type (2018-2029)

4.3 Global Hereditary Angioedema Price by Type (2018-2029)

5.1 Global Hereditary Angioedema Sales by Distribution Channel (2018-2029)

5.1.1 Global Hereditary Angioedema Sales by Distribution Channel (2018-2023)

5.1.2 Global Hereditary Angioedema Sales by Distribution Channel (2024-2029)

5.1.3 Global Hereditary Angioedema Sales Market Share by Distribution Channel (2018-2029)

5.2 Global Hereditary Angioedema Revenue by Distribution Channel (2018-2029)

5.2.1 Global Hereditary Angioedema Revenue by Distribution Channel (2018-2023)

5.2.2 Global Hereditary Angioedema Revenue by Distribution Channel (2024-2029)

5.2.3 Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2018-2029)

5.3 Global Hereditary Angioedema Price by Distribution Channel (2018-2029)

6.1 Pharming Group NV

6.1.1 Pharming Group NV Corporation Information

6.1.2 Pharming Group NV Description and Business Overview

6.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pharming Group NV Hereditary Angioedema Product Portfolio

6.1.5 Pharming Group NV Recent Developments/Updates

6.2 Takeda

6.2.1 Takeda Corporation Information

6.2.2 Takeda Description and Business Overview

6.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Takeda Hereditary Angioedema Product Portfolio

6.2.5 Takeda Recent Developments/Updates

6.3 CSL Limited

6.3.1 CSL Limited Corporation Information

6.3.2 CSL Limited Description and Business Overview

6.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.3.4 CSL Limited Hereditary Angioedema Product Portfolio

6.3.5 CSL Limited Recent Developments/Updates

6.4 iBio Inc.

6.4.1 iBio Inc. Corporation Information

6.4.2 iBio Inc. Description and Business Overview

6.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.4.4 iBio Inc. Hereditary Angioedema Product Portfolio

6.4.5 iBio Inc. Recent Developments/Updates

6.5 BioCryst Pharmaceuticals, Inc.

6.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information

6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview

6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio

6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates

6.6 Ionis Pharmaceuticals, Inc.

6.6.1 Ionis Pharmaceuticals, Inc. Corporation Information

6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview

6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Portfolio

6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates

7.1 Hereditary Angioedema Industry Chain Analysis

7.2 Hereditary Angioedema Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hereditary Angioedema Production Mode & Process

7.4 Hereditary Angioedema Sales and Marketing

7.4.1 Hereditary Angioedema Sales Channels

7.4.2 Hereditary Angioedema Distributors

7.5 Hereditary Angioedema Customers

8.1 Hereditary Angioedema Industry Trends

8.2 Hereditary Angioedema Market Drivers

8.3 Hereditary Angioedema Market Challenges

8.4 Hereditary Angioedema Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Hereditary Angioedema Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Hereditary Angioedema Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million)

    Table 3. Global Hereditary Angioedema Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Hereditary Angioedema Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Hereditary Angioedema Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Hereditary Angioedema Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Hereditary Angioedema Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Hereditary Angioedema Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Hereditary Angioedema, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Hereditary Angioedema, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Hereditary Angioedema, Product Type & Application

    Table 12. Global Key Manufacturers of Hereditary Angioedema, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Hereditary Angioedema by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Hereditary Angioedema Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Hereditary Angioedema Sales by Region (2018-2023) & (K Units)

    Table 18. Global Hereditary Angioedema Sales Market Share by Region (2018-2023)

    Table 19. Global Hereditary Angioedema Sales by Region (2024-2029) & (K Units)

    Table 20. Global Hereditary Angioedema Sales Market Share by Region (2024-2029)

    Table 21. Global Hereditary Angioedema Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Hereditary Angioedema Revenue Market Share by Region (2018-2023)

    Table 23. Global Hereditary Angioedema Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Hereditary Angioedema Revenue Market Share by Region (2024-2029)

    Table 25. North America Hereditary Angioedema Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Hereditary Angioedema Sales by Country (2018-2023) & (K Units)

    Table 27. North America Hereditary Angioedema Sales by Country (2024-2029) & (K Units)

    Table 28. North America Hereditary Angioedema Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Hereditary Angioedema Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Hereditary Angioedema Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Hereditary Angioedema Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Hereditary Angioedema Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Hereditary Angioedema Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Hereditary Angioedema Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Hereditary Angioedema Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Hereditary Angioedema Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Hereditary Angioedema Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Hereditary Angioedema Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Hereditary Angioedema Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Hereditary Angioedema Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Hereditary Angioedema Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Hereditary Angioedema Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Hereditary Angioedema Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Hereditary Angioedema Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Hereditary Angioedema Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Hereditary Angioedema Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Hereditary Angioedema Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Hereditary Angioedema Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Hereditary Angioedema Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Hereditary Angioedema Sales (K Units) by Type (2018-2023)

    Table 51. Global Hereditary Angioedema Sales (K Units) by Type (2024-2029)

    Table 52. Global Hereditary Angioedema Sales Market Share by Type (2018-2023)

    Table 53. Global Hereditary Angioedema Sales Market Share by Type (2024-2029)

    Table 54. Global Hereditary Angioedema Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Hereditary Angioedema Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Hereditary Angioedema Revenue Market Share by Type (2018-2023)

    Table 57. Global Hereditary Angioedema Revenue Market Share by Type (2024-2029)

    Table 58. Global Hereditary Angioedema Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Hereditary Angioedema Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Hereditary Angioedema Sales (K Units) by Distribution Channel (2018-2023)

    Table 61. Global Hereditary Angioedema Sales (K Units) by Distribution Channel (2024-2029)

    Table 62. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2018-2023)

    Table 63. Global Hereditary Angioedema Sales Market Share by Distribution Channel (2024-2029)

    Table 64. Global Hereditary Angioedema Revenue (US$ Million) by Distribution Channel (2018-2023)

    Table 65. Global Hereditary Angioedema Revenue (US$ Million) by Distribution Channel (2024-2029)

    Table 66. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2018-2023)

    Table 67. Global Hereditary Angioedema Revenue Market Share by Distribution Channel (2024-2029)

    Table 68. Global Hereditary Angioedema Price (USD/Unit) by Distribution Channel (2018-2023)

    Table 69. Global Hereditary Angioedema Price (USD/Unit) by Distribution Channel (2024-2029)

    Table 70. Pharming Group NV Corporation Information

    Table 71. Pharming Group NV Description and Business Overview

    Table 72. Pharming Group NV Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Pharming Group NV Hereditary Angioedema Product

    Table 74. Pharming Group NV Recent Developments/Updates

    Table 75. Takeda Corporation Information

    Table 76. Takeda Description and Business Overview

    Table 77. Takeda Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Takeda Hereditary Angioedema Product

    Table 79. Takeda Recent Developments/Updates

    Table 80. CSL Limited Corporation Information

    Table 81. CSL Limited Description and Business Overview

    Table 82. CSL Limited Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. CSL Limited Hereditary Angioedema Product

    Table 84. CSL Limited Recent Developments/Updates

    Table 85. iBio Inc. Corporation Information

    Table 86. iBio Inc. Description and Business Overview

    Table 87. iBio Inc. Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. iBio Inc. Hereditary Angioedema Product

    Table 89. iBio Inc. Recent Developments/Updates

    Table 90. BioCryst Pharmaceuticals, Inc. Corporation Information

    Table 91. BioCryst Pharmaceuticals, Inc. Description and Business Overview

    Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product

    Table 94. BioCryst Pharmaceuticals, Inc. Recent Developments/Updates

    Table 95. Ionis Pharmaceuticals, Inc. Corporation Information

    Table 96. Ionis Pharmaceuticals, Inc. Description and Business Overview

    Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product

    Table 99. Ionis Pharmaceuticals, Inc. Recent Developments/Updates

    Table 100. Key Raw Materials Lists

    Table 101. Raw Materials Key Suppliers Lists

    Table 102. Hereditary Angioedema Distributors List

    Table 103. Hereditary Angioedema Customers List

    Table 104. Hereditary Angioedema Market Trends

    Table 105. Hereditary Angioedema Market Drivers

    Table 106. Hereditary Angioedema Market Challenges

    Table 107. Hereditary Angioedema Market Restraints

    Table 108. Research Programs/Design for This Report

    Table 109. Key Data Information from Secondary Sources

    Table 110. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Hereditary Angioedema

    Figure 2. Global Hereditary Angioedema Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Hereditary Angioedema Market Share by Type in 2022 & 2029

    Figure 4. C1 Esterase Inhibitor Product Picture

    Figure 5. Kallikrein Inhibitor Product Picture

    Figure 6. Selective Bradykinin B2 Receptor Antagonist Product Picture

    Figure 7. Global Hereditary Angioedema Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million)

    Figure 8. Global Hereditary Angioedema Market Share by Distribution Channel in 2022 & 2029

    Figure 9. Retail Pharmacies

    Figure 10. Hospital Pharmacies

    Figure 11. Online Pharmacies

    Figure 12. Global Hereditary Angioedema Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Hereditary Angioedema Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Hereditary Angioedema Sales (2018-2029) & (K Units)

    Figure 15. Global Hereditary Angioedema Average Price (USD/Unit) & (2018-2029)

    Figure 16. Hereditary Angioedema Report Years Considered

    Figure 17. Hereditary Angioedema Sales Share by Manufacturers in 2022

    Figure 18. Global Hereditary Angioedema Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Hereditary Angioedema Players: Market Share by Revenue in 2022

    Figure 20. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Hereditary Angioedema Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Hereditary Angioedema Sales Market Share by Country (2018-2029)

    Figure 23. North America Hereditary Angioedema Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Hereditary Angioedema Sales Market Share by Country (2018-2029)

    Figure 27. Europe Hereditary Angioedema Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Hereditary Angioedema Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Hereditary Angioedema Revenue Market Share by Region (2018-2029)

    Figure 35. China Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Hereditary Angioedema Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Hereditary Angioedema Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Hereditary Angioedema Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Hereditary Angioedema Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. U.A.E Hereditary Angioedema Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Hereditary Angioedema by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Hereditary Angioedema by Type (2018-2029)

    Figure 57. Global Hereditary Angioedema Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Hereditary Angioedema by Distribution Channel (2018-2029)

    Figure 59. Global Revenue Market Share of Hereditary Angioedema by Distribution Channel (2018-2029)

    Figure 60. Global Hereditary Angioedema Price (USD/Unit) by Distribution Channel (2018-2029)

    Figure 61. Hereditary Angioedema Value Chain

    Figure 62. Hereditary Angioedema Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed